BERGENBIO ASA has a total of 41 patent applications. It increased the IP activity by 200.0%. Its first patent ever was published in 2008. It filed its patents most often in United States, EPO (European Patent Office) and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are KAIHUI SCIENCE & TECH DEVELOPMENT SHANGHAI CO LTD, CANBAS CO LTD and DANA-FARBER CANCER INSTITUTE INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 13 | |
#2 | EPO (European Patent Office) | 9 | |
#3 | Australia | 6 | |
#4 | United Kingdom | 5 | |
#5 | Mexico | 2 | |
#6 | WIPO (World Intellectual Property Organization) | 2 | |
#7 | Canada | 1 | |
#8 | Hungary | 1 | |
#9 | Japan | 1 | |
#10 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Organic fine chemistry | |
#5 | Environmental technology | |
#6 | Foods and drinks |
# | Name | Total Patents |
---|---|---|
#1 | Nilsson Linn Hodneland | 11 |
#2 | Micklem David Robert | 11 |
#3 | Kiprijanov Sergej | 10 |
#4 | Ahmed Lavina | 9 |
#5 | Haugen Hallvard | 8 |
#6 | Naylor Alan | 7 |
#7 | Watts John Paul | 7 |
#8 | Shiers Jason John | 7 |
#9 | Wrigglesworth Joseph William | 7 |
#10 | Quddus Mohammed Abdul | 7 |
Publication | Filing date | Title |
---|---|---|
GB202102530D0 | Method of selecting patients for treatment with combination therapy | |
GB202018725D0 | Methods of selecting patients for treatment with combination therapy | |
GB202006072D0 | Method of selecting patients for treatment with cmbination therapy | |
EP3794352A1 | Serum biomarkers | |
GB201817024D0 | Serum biomarkers | |
GB201816764D0 | Serum biomarkers | |
AU2015370911A1 | Inhibitors of Akt kinase | |
EP2235179A2 | Methods for creating and identifying functional rna interference elements |